BIOLASE

BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Lake Forest, CA.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

BIOLASE reports strong Q1 performance, eyes profitability through market growth

BIOLASE's Q1 2024 earnings reflect a robust performance with growth in sales and improved financial metrics. The company's strategic focus on accelerating dental laser adoption and operational enhancements position it well for future success. While challenges exist in achieving profitability, BIOLASE's opportunities in the dental market and growth initiatives offer a positive outlook.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1984 and is headquartered in Lake Forest, CA.

Meta Materials

MannKind

Romeo Power

Inuvo

DatChat

Investing in penny stocks can be an intriguing numbers game. With many stocks to choose from, a handful are bound to be winners.

The 6 Best Penny Stocks to Buy for September

Which reopening penny stocks are on your September watchlist? The post Reopening Penny Stocks to Buy in September?

Reopening Penny Stocks to Buy in September? 3 to Watch

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider BIOLASE (BIOL).

Can BIOLASE (BIOL) Stock Continue to Grow Earnings?

FOOTHILL RANCH, Calif., Aug. 16, 2021 /PRNewswire/ -- Demonstrating a deep commitment to expanding the core capabilities and diversity of its Board of Directors, BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has appointed three new board members to its Board of Directors (the "Board"), effective immediately.

BIOLASE Expands Core Capabilities As It Appoints Three New Board Members With Significant Dental Experience

Asensus Surgical

Oragenics

Trading biotech penny stocks? Here's 3 you don't want to miss The post 3 Biotech Penny Stocks To Watch Making Big Waves in 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Biotech Penny Stocks To Watch Making Big Waves in 2021

Biolase Inc (NASDAQ: BIOL) shares are trading higher on strong volume after it reported Q2 sales of $9.1 million, +211% Y/Y, edging out a consensus of $8.31 million. Over 70% of U.S. laser sales came from new customers, continuing a positive trend, and more than 35% of U.S. Waterlase sales came from dental specialists.

Biolase Stock Is Trading Higher On Better Than Expected Q2 Earnings

The shares of BIOLASE Inc (NASDAQ: BIOL) increased by over 30% pre-market. This is why it happened.

BIOLASE Shares Increase Over 30% Pre-Market: Why It Happened

BIOLASE, Inc. (BIOL) CEO John Beaver on Q2 2021 Results - Earnings Call Transcript

Shares of Biolase (NASDAQ:BIOL) moved higher by 31.4% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 83.33% over the past year to ($0.02), which beat the estimate of ($0.04).

Biolase: Q2 Earnings Insights

FOOTHILL RANCH, Calif., Aug. 12, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for its second quarter ended June 30, 2021 and provided third quarter 2021 revenue guidance.

BIOLASE Reports Significantly Improved Revenue In Its Second Quarter As Continued High Demand For Dental Lasers From New Customers Fueled Growth

FOOTHILL RANCH, Calif., Aug. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2021 financial and operating results on Thursday, August 12, 2021 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m.

BIOLASE, Inc. To Report Second Quarter 2021 Results On August 12, 2021

Acasti Pharma

Adamis Pharmaceuticals

Ampio Pharmaceuticals Inc

Jaguar Health

Northwest Biotherapeutics, Inc.

Are these the best biotech penny stocks to watch right now? The post Best Biotech Penny Stocks In Summer 2021?

Best Biotech Penny Stocks In Summer 2021? 7 For Your Watchlist

Aptinyx Inc

Xinyuan Real Estate Co Ltd

Top growth penny stocks to watch this year? Check these 3 out right now The post Best Growth Penny Stocks for 2021, Are Small-Caps Worth Watching?

Best Growth Penny Stocks for 2021, Are Small-Caps Worth Watching?

FOOTHILL RANCH, Calif., June 3, 2021 /PRNewswire/ --  BIOLASE, Inc.  (NASDAQ: BIOL), the global leader in dental lasers, announced today that recent data published in two journals, the I nternational Journal of Periodontics & Restorative Dentistry and Lase rs in Medical Science , demonstrates BIOLASE's Waterlase Er,Cr:YSGG laser technology can be beneficial for the treatment of peri-implantitis in patients suffering from the inflammatory disease.

Recent Studies Demonstrate BIOLASE's Waterlase Laser Technology is Beneficial for Treatment of Peri-Implantitis

FOOTHILL RANCH, Calif., June 1, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will be presenting at the Summer Solstice Best Ideas from the Buy Side Conference being held virtually on June 1 st – June 4 th, 2021.

BIOLASE to Present at the Summer Solstice Best Ideas From the Buy Side Conference on June 2, 2021

FOOTHILL RANCH, Calif., May 18, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, partnered with Healthy Smiles For Kids of Orange County (Healthy Smiles) to host a pediatric dental laser training on May 8.

BIOLASE Hosts Pediatric Dental Laser Training with Healthy Smiles for Kids of Orange County

Blue Hat Interactive Entertainment Technology

Castor Maritime Inc

Golden Minerals Company

Motus GI Hlds

Waitr Holdings Inc

It can be difficult to find cheap stocks worth buying. But these seven companies look promising and are all under $3.

7 Cheap Stocks to Buy Now Under $3

Biolase Inc (NASDAQ: BIOL) reported a Q1 EPS loss of $(0.06), which missed the analyst consensus of $(0.05) loss, though it improved from a loss of $0.19 reported a year ago. Net revenue of $8.1 million beat the analyst consensus of $7.79 million and increase 70% Y/Y as Q1 2020 was impacted by the COVID-19 pandemic.

Biolase Stock Jumps On Q1 Earnings Beat, Strong Demand For Dental Lasers, Q2 Outlook

Bionano Genomics

SNDL Inc.

These penny stocks gapped up big this morning; are they worth watching? The post 3 Penny Stocks That Gapped Up Big in Early Morning Trading appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Penny Stocks That Gapped Up Big in Early Morning Trading

The stock price of BIOLASE Inc (NASDAQ: BIOL) increased by over 30% pre-market. This is why it happened.

BIOLASE (BIOL) Stock: Over 30% Increase Pre-Market Explanation

BIOLASE, Inc. (BIOL) CEO John Beaver on Q1 2021 Results - Earnings Call Transcript

Shares of Biolase (NASDAQ:BIOL) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 68.42% year over year to ($0.06), which missed the estimate of ($0.05).

Recap: Biolase Q1 Earnings

FOOTHILL RANCH, Calif., May 13, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for its first quarter ended March 31, 2021.

BIOLASE Reports 70% Revenue Growth In First Quarter 2021; Continued High Demand From New Users For Dental Lasers

Atossa Genetics

Centennial Resource Development

Phio Pharmaceuticals Corp

Reddit penny stocks continue to see momentum; here's 4 to watch with higher than average volume The post 4 Hot Reddit Penny Stocks With Higher Than Average Volume appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Hot Reddit Penny Stocks With Higher Than Average Volume

FOOTHILL RANCH, Calif., May 6, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2021 financial and operating results on Thursday, May 13, 2021 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m.

News for BIOLASE Stock (BIOL)